A Breakthrough
Treatment
FOR COPD
is Here
DUPIXENT is an add-on maintenance treatment for adults with
inadequately controlled chronic obstructive pulmonary disease
(COPD) and a high number of blood eosinophils (a type of white
blood cell that may contribute to your COPD).
SHARE THE NEWS: DUPIXENT IS APPROVED IN COPD!
The First and Only
Treatment of its Kind
for COPD
WHEN USED WITH COPD INHALERS,* DUPIXENT CAN:
Reduce the number
of
flare-ups
of
flare-ups
Help you breathe better
with long-lasting lung
function improvement
with long-lasting lung
function improvement
Lead to improvement
in patients’ day-to-day
lives†
in patients’ day-to-day
lives†
View the possible side effects of DUPIXENT in patients with inadequately controlled chronic obstructive
pulmonary
disease. The most common side effects associated with DUPIXENT were injection site reactions,
common cold symptoms (nasopharyngitis), high count of a certain white blood cell (eosinophilia), viral
infection, back pain, inflammation inside the nose (rhinitis), diarrhea, gastritis, joint pain (arthralgia),
toothache, headache, and urinary tract infection.
*COPD inhalers are considered standard of care (SOC), which refers to a typical treatment approach
prescribed by a healthcare professional for COPD.
†Assessed by SGRQ, a quality of life tool which measures COPD symptoms, physical activity, emotional well-
being,
and social functioning. In two trials, 51% of patients who received DUPIXENT + SOC experienced a
quality of life
improvement vs 43% and 47% with placebo + SOC. In one trial, results are descriptive, no
definitive conclusions can be made.
Financial Support
Copay Card Program
With the DUPIXENT MyWay® Copay Card, eligible, commercially insured patients may pay as little as $0* copay per fill of DUPIXENT. If you’re eligible, you can sign up online and your card will be sent via email. View full copay card Terms & Restrictions.
Patient Assistance Program
Help with out-of-pocket costs may be available for eligible uninsured, underinsured, and Medicare Part D patients through the DUPIXENT MyWay Patient Assistance Program.
For financial support information, dial
1‑844‑DUPIXENT (1-844-387-4936), option 1
Monday-Friday, 8 am-9 pm ET
*Maximum of $13,000 per patient per calendar year
Not an actual patient
Learn more about
DUPIXENT for COPD
To better understand how inflammation can impact
COPD and how DUPIXENT may help, download the
patient brochure.
Not an actual patient
Not an actual patient
GET EMAIL UPDATES
Sign up to receive DUPIXENT emails and resources providing more information on how DUPIXENT works, its cost and coverage, accessing DUPIXENT, injection support, and more.
All fields are required